MedTrace Logo

Asprosin Level in Individuals with Periodontal Disease

NCT06627972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2024-10-04

No results posted yet for this study

Summary

The aim of this study was to investigate the levels of asprosin hormone and tumour necrosis factor alpha (TNF-α) in gingival crevicular fluids and to compare its level with those in saliva and serum in patients with gingivitis and periodontitis.

Conditions

  • Periodontitis
  • Periodontal Health
  • Gingivitis

Sponsors & Collaborators

  • Mustafa Kemal University

    lead OTHER

Principal Investigators

  • Abdulsamet Tanık, PhD · Adiyaman University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-07-31
Completion
2022-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627972 on ClinicalTrials.gov